1 completed, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow Helminth Infection: new trials by email Literature Review of Helminth Infection trials Research Report on Helminth Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Twice Yearly Treatment for the Control of LF 400 μg/kg Ivermectin + 400 mg Albendazole - Lymphatic Filariasis, Helminth Infection | Phase 4 | Completed | Noguchi Memorial Institute for Medical Research | 1462 | 2017-05-19 | 2020-02-26 |
| Intestinal Microbiome Post-Azythromycin/Albendazole Treatment Azithromycin, Albendazole, Delayed treatment - Helminth Infection | Phase 4 | Withdrawn | University of California, San Francisco | 2017-01-01 | 2021-06-28 |
Trematode Infections (2) · Elephantiasis, Filarial (1)
Helminthiasis (2) · Infections (2) · Parasitic Diseases (2) · Filariasis (1) · Hemic and Lymphatic Diseases (1) · Lymphatic Diseases (1) · Lymphedema (1) · Mosquito-Borne Diseases (1) · Nematode Infections (1) · Secernentea Infections (1) · Spirurida Infections (1) · Vector Borne Diseases (1)
Albendazole (2) · Azithromycin (1) · Ivermectin (1) · Treatment Delay (1)
Noguchi Memorial Institute for Medical Research (1) · University of California, San Francisco (1)
Ethiopia (1) · Ghana (1)
Dziedzom K de Souza, PhD (1) · Jeremy Keenan, MD, MPH (1)